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http:WHAT THIS PAPER ADDS
Most previous publications on treatment with open abdomen (OA) are on mixed patient cohorts. This article
reports on a fairly large prospective cohort of aortic aneurysm patients who have been treated in a uniform way.
The study shows that with the combination of negative topical pressure draining effectively the abdomen, and
mesh-mediated traction pulling the fascia towards the midline, all surviving patients were possible to close
without synthetic material. No patient was left with a giant hernia. The study also showed that prolonged OA
treatment is a morbid procedure. If OA is necessary, the described method is effective.Objectives: Open abdomen (OA) treatment is sometimes necessary after surgery for aortic aneurysm (AA), to
prevent or treat abdominal compartment syndrome (ACS). A multicentre study evaluating vacuum-assisted
wound closure (100e150 mmHg) and mesh-mediated fascial traction (VAWCM) was performed.
Methods: All patients treated with OA after AA repair (2006e2009) were prospectively registered at four centres;
those treated <5 days were excluded. All surviving patients underwent a 1-year follow-up, including computed
tomography (CT) examination.
Results: Among 1041 patients treated with open or endovascular repair of AA, 28 (2.9%) had OA treatment with
VAWCM; another two had VAWCM after hybrid operations for thoraco-abdominal AA. Eighteen (60%) were
operated on for rupture and 12 (40%) electively. Eight had suprarenal or thoraco-abdominal aneurysms. Eight
(27%) died within 30 days, none due to OA-related complications. Four died before abdominal closure; primary
delayed fascial closure was achieved in all survivors. One-year mortality was 50%. Ten (33%) had bowel ischaemia
requiring bowel resection.
Late potential OA-related infectious complications occurred in ﬁve (17%), all of whom ﬁrst developed intestinal
ischaemia: entero-atmospheric ﬁstulae (two), graft infections (two), aorto-enteric ﬁstula (one). One year follow-
up with clinical evaluation and CT showed no signs of graft infection. Incisional hernias occurred in 9 of 15
patients (60%); only three were symptomatic.
Conclusion: VAWCM provided high fascial closure rate after AA repair and long-term OA treatment. Infectious
complications occur after intestinal ischaemia and prolonged OA treatment, and are often fatal. The poor
prognosis among patients needing OA after AA surgery may be improved by using VAWCM, permitting earlier
closure.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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septic abdomen, the tense abdomen after resuscitation, in
damage control situations, or to treat the abdominal
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//dx.doi.org/10.1016/j.ejvs.2013.01.041Management of the OA is a clinical challenge. Several
techniques were developed, aiming to allow abdominal
closure as soon as possible without compromising the
patient’s physiologic condition. In younger patients,
predominantly suffering from trauma, fascial closure of the
OA within 1 week is often possible.5 In elderly patients
undergoing treatment of OA after aortic aneurysm (AA)
repair a longer duration is often required, and therefore
a different technique is warranted in this subgroup of
patients. The chosen OA technique must prevent adhesions
between the intestines and the bowel, lateralisation of the
K. Sörelius et al. 589bowel wall and contamination, thus permitting an early
closure, which is the most important factor to avoid
complications.2 The longer the duration of OA treatment,
the greater the risk becomes of developing serious
complications such as graft infections, entero-atmospheric
ﬁstulae (EAFs) and other infections. We developed a novel
technique, combining vacuum-assisted wound closure
(VAWC) and mesh-mediated fascial traction (VAWCM).6 To
evaluate VAWCM a prospective multicentre study was
performed on 111 patients treated for vascular or visceral
pathologies, as well as trauma. The in-hospital mortality was
29.7%, and fascial closure rate was 89% among survivors.
No patient was left with a large planned ventral hernia.
Eight patients (7.2%) developed EAF, seven of whom had
been operated on for intestinal ischaemia. EAF was an
independent risk factor for failure of abdominal closure and
fatal outcome.7 This study is a subgroup analysis of the
patients treated for AA.
PATIENTS AND METHODS
A multicentre prospective study was performed including all
consecutive patients treated with OA at four study centres
(Falun, Gävle, Malmö and Uppsala) between April 2006 and
August 2009. Criteria for exclusion were abdominal wall
hernia before OA treatment, anticipated OA treatment
lasting <5 days (patients treated with OA <5 days often
received VAWC only, and not VAWCM) and non-midline
incisions.7 The study was approved by the ethics
committee of Lund University and registered at http://
www.clinicaltrials.gov (NCT00494793).
This study is a subgroup analysis of the patients treated
with OA with VAWCM after operation for AA; the technique
used in all patients is described below. All surviving patients
underwent a 1-year follow-up examination with clinical
assessment as well as with a computed tomography (CT) of
the abdomen to detect late complications, in particular
graft infections, EAFs and incisional hernias.Table 1. Classiﬁcation of the open abdomen (OA).2
Grade Description
1A Clean OA without adherence between bowel and
abdominal wall or ﬁxity (lateralisation of the
abdominal wall)
1B Contaminated OA without adherence/ﬁxity
2A Clean OA developing adherence/ﬁxity
2B Contaminated OA developing adherence/ﬁxity
3 OA complicated by ﬁstula formation
4 Frozen OA with adherent/ﬁxed bowel, unable to
close surgically, with or without ﬁstulaDeﬁnitions
Intra-abdominal pressure (IAP) was measured intermittently
as urinary bladder pressure through an indwelling catheter
by means of the Foley manometer technique8 (Holtech
Medical, Charlottenlund, Denmark), before and repeatedly
after initiation of OA treatment. Urinary bladder pressure,
when measured correctly, reﬂects IAP and is recommended
by the World Society of the Abdominal Compartment
Syndrome.9 Intra-abdominal hypertension (IAH) and ACS
were deﬁned according to the World Society of the
Abdominal Compartment Syndrome consensus deﬁnitions.9
ACS is deﬁned as IAP  20 mmHg and/or abdominal
perfusion pressure APP < 60 mmHg (APP ¼ MAP  IAP),9
measured at least twice, with newly developed organ
dysfunction or failure. Indications for OA in this study were
development of ACS, IAH > 20 mmHg and/or an abdomen
too tense to close. Incisional hernia was deﬁned as any
abdominal wall gap with or without bulge in the area of
a postoperative scar perceptible or palpable by clinicalexamination or imaging (CT). Graft infection was deﬁned
according to Szilagyi.10
The Sequential Organ Failure Assessment (SOFA) score11
was used as an estimate of organ failure. Individual organ
score ranges from 0 to 4, and the maximum score is 24.
IAP and SOFA score were evaluated immediately before
and the morning after initiation of OA treatment. IAP was
measured 1 and 3 h after the abdomen had been left
open, and after each redressing. Classiﬁcation of OA
status2 was performed at initiation of OA treatment, at
redressings and at fascial closure or in the event of
death before closure. The grading system is described in
Table 1.Vacuum-assisted wound closure and mesh-mediated
fascial traction
The techniques of VAWC and VAWCM were described
earlier.6,7 Patients were initially treated with only VAWC, to
avoid prolonging the laparotomy as part of the damage
control surgery.1 A polypropylene mesh was applied at the
ﬁrst redressing after 2e3 days. A 30  30-cm mesh
(Prolene; Ethicon, Johnson & Johnson, Somerville, NJ,
USA) was divided in two halves and sutured to the fascial
edges on each side with a running 0 polypropylene suture
(Prolene; Fig. 1). A VAWC system (V.A.C Abdominal
Dressing System; KCI, San Antonio, TX, USA) was applied;
the perforated polyethylene sheet with a central thin
polyurethane sponge was placed intra-abdominally,
covering the viscera, and tucked under the abdominal
wall far out laterally on both sides (Fig. 2). The two mesh
halves were then sutured in the midline with a running
0 polypropylene suture, ventral to the polyethylene sheet.
The thick polyurethane sponge was placed on top of the
polypropylene mesh, and the wound was covered with
occlusive self-adhesive thin polyethylene sheets. A contin-
uous topical negative pressure (TNP) of 100e150 mmHg
was applied (Fig. 3).
The mesh was opened in the midline, the inner layer of
the V.A.C. dressing changed and the mesh tightened by
approximating the mesh towards the midline, under general
anaesthesia every 2e3 days. Dressing changes without
mesh tightening were sometimes performed, when a ﬂuid
overload resulted in a risk to develop a secondary ACS.
Finally, the entire mesh was removed after cutting the
Figure 3. The black foam is applied above the mesh. The dressing is
covered with plastic sponge (S) and negative topical pressure is
applied through the suction device (VAC). This patient had stomas
placed far out laterally, a colonostomy to the left and an ileostomy
to the right, to be able to achieve an effective sealing.
Figure 1. The two mesh halves (M) have been sutured to the fascial
edges around the open abdomen.
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side. The fascia was then closed with a running 0 poly-
dioxanone suture (PDS II, Ethicon, Johnson & Johnson,
Somerville, NJ, USA), by means of a standardised suturing
technique aiming at a suture length to wound length ratio
of at least 4:1.12 Successful delayed primary fascial closure
was deﬁned as complete closure of the whole length of the
incised fascia.Statistical analysis
Continuous variables were expressed as median (range),
and group differences were analysed by means of the
ManneWhitney U or the Wilcoxon signed rank test.
Dichotomous variables were analysed with the Fisher exact
test. Statistical analysis was performed using IBM SPSS
Statistics version 20.0 (SPSS, Chicago, IL, USA).Figure 2. Each mesh half is retracted laterally and upwards to open
the midline wound. The inner layer of the Abdominal VAC dressing
(P) is applied to prevent adhesions between the intestines and the
bowel wall, and to protect the bowel from contact with the mesh.
The mesh halves (M) are then joined with a running 0 poly-
propylene suture.RESULTS
Thirty patients were treated with VAWCM after AA surgery,
with open, endovascular or hybrid approach. Median age
was 71 years (range 49e87 years): 26 (87%) were men.
Eighteen patients (60%) were operated on for ruptured AA
and 12 (40%) electively. Eight patients (27%) had suprarenal
or thoraco-abdominal aneurysms. Pathology and operative
techniques are described in Table 2. The frequencies of OA
treatment, in the different subgroups of patients, are
described in Table 3. The two patients who were treated
with OA after hybrid procedures for thoraco-abdominal or
suprarenal aneurysms were excluded from these calcula-
tions, since most of those patients were operated on with
an extraperitoneal approach through a paramedian
abdominal incision and thus were excluded from this study
that excluded non-midline incisions.
The patients had a history of smoking (70%), hyperten-
sion (70%), cardiac disease (47%), pulmonary disease (20%),
renal insufﬁciency (20%), diabetes, cerebrovascular disease
and previous vascular surgery (13% each).Table 2. Types of surgical procedure performed among 30 patients
treated for open abdomen after aortic repair.
Surgical management Ruptured
aneurysm
Elective
aneurysm
Open repair 14 3
OR of suprarenal
aneurysm
1 4
EVAR 3 2
BEVAR 0 1
Hybrid approach
(OR þ TEVAR)
0 2
Total 18 12
OR, open repair; EVAR, endovascular aortic repair; BEVAR,
branched EVAR; TEVAR, thoracic EVAR.
Table 3. Need for open abdomen treatment depending on
pathology and type of procedure at the four study centres.
Pathology/procedure No of procedures No OA OA%
Intact infrarenal
AA, OR
303 3 0.9
Intact infrarenal
AA, EVAR
455 2 0.4
Ruptured infrarenal
AA, OR
115 14 2.5
Ruptured infrarenal
AA, EVAR
86 3 3.4
Intact suprarenal
AAa, OR
11 4 36.4
Intact suprarenal
AAa, BEVAR/TEVAR
52 1 1.9
Ruptured suprarenal
AAa, OR
1 1 100
Ruptured suprarenal
AAa, BEVAR/TEVAR
18 0 0
Totalb 1041 28 2.9
a Includes thoracic, thoracoabdominal, supra- and juxtarenal aortic
aneurysms. AA, aortic aneurysm; OR, open repair; EVAR, endo-
vascular aortic repair; BEVAR, branched EVAR; TEVAR, thoracic
EVAR.
b Two patients with hybrid operations (OR and TEVAR) for supra-
renal or thoraco-abdominal aneurysms were excluded from this
analysis.
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The indications for OA treatment were ACS in 13 patients
(43%) and documented IAH in 4 patients (13%). In the
remaining 13 patients it was considered impossible or
unwise to close the abdomen, due to considerable tension
of the abdominal wall at the end of the laparotomy, nine at
primary and four at relaparotomy. Among the 13 patients
with ACS nine were operated on for ruptured aneurysms
and four electively. The abdomen was left open at primary
or after relaparotomy in 9 (30%) and 21 (70%) patients,
respectively.Effect of initiation of OA treatment on IAP
The median IAP before OA treatment in 17 patients where
we had a preoperative IAP measurement was 24 (14e
43) mmHg, which decreased signiﬁcantly to 12 (5e
19) mmHg after initiation of OA (p < 0.001), 1e3 h after
completion of the operation.OA treatment and organ failure
The median SOFA score before OA treatment was 9.5 (1e
16) and 10.3 (4e15) points 24 h after initiation of OA
(p ¼ 0.34). Three of 22 patients had a decrease in SOFA
score with more than two points 24 h after initiation of OA.
The median PaO2/FiO2 ratio was 23 (9e50) kPa before
treatment, increasing to 30 (12e53) kPa after initiation of
OA treatment (p ¼ 0.04). Bilirubin increased from 16 to 19
(p ¼ 0.03). Creatinine levels (p ¼ 0.07) and platelet count
(p ¼ 0.14) remained unchanged.VAWCM
The median fascial diastasis immediately after initiation of
OA treatment was 21 (10e32) cm. The median duration of
VAWC was 17 (4e87) days, with VAWCM for 14 (2e84)
days. In the subgroup of 25 patients who survived until
closure the median duration of VAWC was 17 (4e87) days
with VAWCM for 15 (2e84) days. The median number of
mesh-tightening procedures was 3.6 (0e8) in the group
with ﬁnal abdominal closure and 3.8 (0e8) in all patients.
No patient developed a secondary ACS during or after the
mesh-tightening procedure. The patient who had the
longest treatment (87 days) had 24 redressings, but it was
only possible to tighten the mesh 8 times. Continuous TNPs
of 100 mmHg (4 patients), 125 mmHg (21 patients) and
150 mmHg (5 patients) were used.
Classiﬁcation of OA
OA at the start of treatment was classiﬁed as grade 1A in 29
patients (97%) and 1B in 1 patient. At the end of OA
treatment (before closure or at time of death) it was grade
1A in 26 patients (87%), grade 1B in 2 patients (7%), grade 3
and 4 patients in one each (3%). The most serious grades of
OA recorded at any time in each patient were 1A in 24
patients (80%), 1B in 3 patients (10%), grade 3 in 2 patients
(7%) and grade 4 in 1 patient (3%). The OA grade at the end,
compared to at the start of OA treatment, was improved in
1 patient, unchanged in 25 patients (83.3%) and worsened
in 4 patients (13.3%). Among the 25 patients with an
unchanged grading, all patients had OA grade 1A at the
start as well as at the end of treatment. Two had contam-
ination after intestinal ischaemia and bowel resection,
resulting in a more complex grade.
Fascial closure
Four patients died with an OA before fascial closure was
possible. One patient had his abdomen closed after 87 days
with a Permacol patch (Covidien, Mansﬁeld, MA, USA),
placed in the central part of the wound, but died on day
107. In the surviving 25 patients complete delayed primary
fascial closure was achieved in all patients. No patient
treated with VAWCM had a large incisional ventral hernia
remaining for secondary granulation of the wound and later
repair. The median suture to wound length ratio at closure,
measured in 17 patients, was 5 (range 3.2e9.2).
Intensive care
The patients spent a median of 20 days (range 3e53) in the
intensive care unit (ICU) and 49 days (8e220) in hospital.
Twenty-nine patients (97%) had ventilator-assisted respira-
tion at some stage of the treatment. Renal replacement
therapy was needed in 17 (57%) and inotropic support in 29
(97%) patients.
Outcome and mortality
Intestinal ischaemia occurred in 10 patients (10/30, 33%),
all of whom needed intestinal resection. Eight had
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OA-related infectious complications occurred in ﬁve
patients (17%). They were all treated for postoperative
intestinal ischaemia, requiring relaparotomy, intestinal
resection and then OA was commenced (Table 4). The two
patients who developed EAF were treated with OA for
a median of 22 days, compared to 13 days among the other
patients. The patient who died after an early graft infection
had stools sucked into the abdominal cavity from a colo-
nostomy, a result of impaired healing.
The 30-day mortality was 27% (8 patients), the in-hospital
mortality was 43% (13 patients) and the 1-year mortality
was 50% (15 patients). In-hospital mortality for patients left
with an OA after primary surgery was 2/9 (22%) compared to
11/21 (52%) after relaparotomy/decompression (p ¼ 0.23).
Patients decompressed for ACS had in-hospital mortality of 8/
13 (62%) compared to 5/17 (29%) among those without ACS
(p ¼ 0.023). Patients operated on for ruptured AA had a 30-
day mortality of 5/18 (28%) compared to 3/12 (25%) among
the electively operated patients. One-year mortality in those
groups were 8/18 (44%) and 8/12 (67%), respectively. Causes
of death were multi-organ failure (four patients), myocardial
infarction (three patients), cardiac failure (two patients),
sepsis (two patients), acute respiratory distress syndrome
(one patient), pneumonia (one patient), cardiac arrest (one
patient) and unknown cause (one patient).
One-year follow-up
All 15 surviving patients were examined clinically and with
CT 1 year after surgery. One patient had previously been
treated conservatively for a graft infection and still had
small gas bubbles near the graft on the CT 1 year after
surgery but they had resolved after another 6 months.
Another patient had signs of periaortic accumulation of
ﬂuid, which on a second CT had regressed. Both patients
lacked clinical signs of infection and had normal CRP values,
after >3 years of follow-up. One patient with endovascular
treatment for an AEF showed no signs of ongoing infection.
Nine patients (9/15, 60%) had developed incisional
midline hernias after a median follow-up of 16 months
(range 12e25), but only three of them (20%) were symp-
tomatic. Six patients had hernias above the umbilicus and
three had hernias below the umbilicus. Among the three
patients with symptomatic hernias, two underwent repair
the third was not ﬁt for surgery.
DISCUSSION
Treatment with OA may be life saving but is a morbid
procedure, requiring repeated redressings in full anaesthesiaTable 4. Infectious complications after OA treatment.
Patient Indication of
aneurysm repair
Procedure Graft related infe
and time after O
1 AAA EVAR EAF day 15
2 TAAA Hybrid EAF day 30
3 rAAA EVAR Graft infection d
4 rAAA EVAR Graft infection d
5 rAAA OR AEF day 30and consuming considerable resources. The best is to avoid
OA treatment all together, by an early proactive non-surgical
management.When this was not possible VAWCM provided
a high fascial closure rate, technique-related complications
were few, but infectious complications occur after prolonged
treatment and are often fatal. Given the facts that no patient
developed a secondary ACS due to a too aggressive tight-
ening and that there was an association between prolonged
OA treatment and serious complications both in the larger
study9 and in this subgroup analysis, it is suspected that the
patients’ abdomens could have been closed more aggres-
sively. With increasing experience, the surgeons tend to
tighten the mesh with more force.
The 30-day mortality in this selected group of elderly
patients with complex aortic disease, often suffering
rupture and suprarenal aneurysm disease, requiring OA
treatment, was 27%. In comparison, patients in general
with a ruptured abdominal aortic aneurysm (AAA) in
Sweden have a 30-day mortality of 36%.13 The battle is not
won at 30 days, however, in these severely diseased
patients. After 1 year the mortality was higher compared to
the same group, 50% versus 43%,14 which may be attrib-
uted to the inclusion of patients treated with suprarenal
AAs in the present study.
The frequency of OA treatment after AA surgery was low,
<1% after elective repair, increasing to approximately 3%
after rupture of an infrarenal AAA, and even further when
suprarenal or thoraco-abdominal aneurysms were treated
(Table 3). All the four hospitals practice measurement of
IAH8 and apply early proactive treatment of IAH with
neuromuscular blockade, colloids and furosemide,8,9 thus
minimising the need for OA treatment.
The incidence of IAH > 20 mmHg after ruptured AAA is
about 50% after OR and approximately 20% after EVAR on
stable patients, and among those approximately half
develop the ACS.15 In a study from the Zürich group, in
which virtually all patients were operated on with EVAR for
rupture, 20% developed ACS.16 In this study, in-hospital
mortality for patients left with an OA after primary
surgery was 22%, after secondary surgery 52%, and 62%
among those decompressed for ACS, signiﬁcantly higher.
Does this imply that we should have been more proactive,
opening the patients before ACS developed, or should we
have left the abdomen open at the primary laparotomy?
There is no simple answer to this question. The patient
group is heterogeneous and subgroups have different risks
of developing ACS, intestinal ischaemia and organ failure.
This particular issue should ideally be addressed in a rand-
omised controlled trial.ction
A
Treatment of graft
related infection
One-year
survival
Drainage with OA No
Drainage with OA No
ay 240 Percutaneous drainage þ antibiotics Yes
ay 25 Percutaneous drainage þ antibiotics No
EVAR þ antibiotics Yes
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iological changes following decompressive laparotomy.
There was a clear decrease in IAP after decompression, but
SOFA scores did not change within 24 h. Hence, the total
SOFA score seems to be an imprecise scoring system to
measure the apparent clinical beneﬁcial effect of abdominal
decompression. The utility of the SOFA score in this scenario
has been questioned by others.17 The results may also imply
that the abdomen was opened too late in some patients.
On the other hand, OA treatment is a morbid procedure.
Patients who develop ACS are very sick, and untreated this
condition is almost 100% lethal, which may explain that it
takes several days to recuperate after such an event.
The most feared complications to OA treatment among
vascular patients are infections, in particular EAFs and graft
infections. In a review performed by Hensbroek et al.18 EAFs
were among the most consistently reported complications
after all techniques of OA treatment. In the same study it was
concluded that VAWCwas associatedwith a low frequency of
intestinal ﬁstula (2.9%). In this study, all patients with infec-
tious complications had previous intestinal ischaemia, and
those who developed EAF had prolonged treatment with OA.
Intestinal ischaemia is a major risk factor. Other studies have
reported higher frequencies of EAF after OA treatment.18
One study reported an association between the use of
gastric or jejunal feeding tubes and EAF during OA treat-
ment,19 a practice avoided in this investigation.
One patient developed an aorto-enteric ﬁstula (AEF) in
the early postoperative period after open repair of
a ruptured AAA. The patient suffered multiple complica-
tions, including bleeding and colonic ischaemia, requiring
two separate relaparotomies and colonic resection, and was
ﬁnally left with an OA. It is uncommon that AEF develops
early postoperatively,20 and it is unlikely that the OA
treatment as such should have caused the AEF that was
very distant from the VAWC device. It is more likely that
there was an injury to the duodenum at one of the three
laparotomies, combined with poor healing due to critical
illness.
Endograft infection after EVAR seldom occurs within the
early postoperative period, more typically 1e3 years after
the endovascular operation.21 It is unlikely that the
contamination of the endovascular device should occur
through the OA, and through the aortic wall, when the
retroperitoneal space is closed. Both patients with stent
graft infections in the present study suffered colonic
ischaemia and had colonostomy. These stent-graft infections
were more likely a result of haematogenic contamination.
The delayed primary fascial closure rate was 100% among
survivors. In comparison, VAWC treatment alone without
mesh-mediated traction resulted in a fascial closure rate of
70% among trauma patients with a mean age of 38 years.5
The high frequency of primary fascial closure rate with the
VAWCM technique has recently been reproduced in two
independent investigations in Finland and Norway.23,24 The
risk of developing incisional hernia, however, was substan-
tial (9/15), probably explained also by high age and cata-
bolic state; the patients spent a mean of 20 days in the ICU.On the other hand, incisional hernia is a recognised late
complication following AAA repair with an incidence of 32e
37%22 even without OA treatment. Furthermore, most of
the identiﬁed hernias were asymptomatic and may not have
been detected without CT, a great difference compared with
the giant hernias that are the result of non-closure.
This study has several limitations, with the most impor-
tant being the relatively small number of patients, and the
fact that they were somewhat heterogeneous. Treating
patients with OA after AA surgery is not a common
procedure, however, and this is among the largest consec-
utive series published. The fact that all patients were
treated according to a common protocol, and studied
prospectively, are strengths. Whether the abdomen is too
tense to close at the end of surgery is subjective, which
unfortunately in a few cases leaves this indication for
treatment with OA in a grey zone based upon experience
and judgement. Furthermore, the follow-up was too short
to detect late graft infections. The patients were well
investigated, however: all were examined clinically and with
CT. Laboratory examinations and FDG-PET/CT18 were per-
formed liberally when an infection was suspected.
CONCLUSION
VAWCM provided a high fascial closure rate after AA repair
and long-term OA treatment. Infectious complications
occurred after intestinal ischaemia and prolonged OA
treatment, and were often fatal. Incisional, asymptomatic
hernias were common. The poor prognosis among patients
needing OA after AA surgery may be improved by using
VAWCM, permitting earlier closure.DISCLOSURES
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